The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of regorafenib in Japanese patients with metastatic colorectal cancer (mCRC) in clinical practice: Interim result from postmarketing surveillance (PMS).
 
Yoshito Komatsu
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Kei Muro
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
Consulting or Advisory Role - Takeda
 
Kensei Yamaguchi
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Takeda
 
Hiroyuki Uetake
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon (Inst)
 
Toshirou Nishida
Honoraria - Bayer Yakuhin; Novartis; Pfizer
Research Funding - Bayer Yakuhin; Novartis
 
Naoya Yamazaki
Honoraria - Bayer Yakuhin; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; GlaxoSmithKline; Kissei Pharmaceutical; Lilly; Maruho; Merck Serono; Ono Pharmaceutical; Takeda; Toray Industries; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Ono Pharmaceutical; Takeda
Speakers' Bureau - Bayer Yakuhin; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; GlaxoSmithKline; Hisamitsu Pharmaceutical; Kissei Pharmaceutical; Lilly; Maruho; Merck Serono; Ono Pharmaceutical; SymBio Pharmaceuticals; Takeda; Toray Industries; Yakult Honsha
Research Funding - Amgen Astellas BioPharma (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takara Bio (Inst)
 
Hajime Takigawa
Consulting or Advisory Role - Bayer Yakuhin; Kyowa Hakko Kirin; Otsuka
Speakers' Bureau - Bayer Yakuhin
Research Funding - Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; Merck Sharp & Dohme; Mitsubishi Tanabe Pharma; Otsuka; Zeria Pharmaceutical
 
Yoko Hamada
Employment - Bayer Yakuhin
Travel, Accommodations, Expenses - Bayer Yakuhin
 
Masayuki Chosa
Employment - Bayer Yakuhin
Stock and Other Ownership Interests - Bayer Yakuhin
Travel, Accommodations, Expenses - Bayer Yakuhin
 
Toshiyuki Sunaya
Employment - Bayer Yakuhin
Travel, Accommodations, Expenses - Bayer Yakuhin
 
Yuka Yamamoto
Employment - Bayer Yakuhin
Travel, Accommodations, Expenses - Bayer Yakuhin
 
Yuichiro Ito
Employment - Bayer Yakuhin
Stock and Other Ownership Interests - Bayer Yakuhin
Travel, Accommodations, Expenses - Bayer Yakuhin
 
Toshiaki Watanabe
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Taiho Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Kenichi Sugihara
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Merck Serono; Taiho Pharmaceutical
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha